APA (7th ed.) Citation

Cortés, J. E., & Müller, M. C. (2018). Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: Final 5-year results of the phase 2 PACE trial. Blood, 132(4), . https://doi.org/10.1182/blood-2016-09-739086

Chicago Style (17th ed.) Citation

Cortés, Jorge Eduardo, and Martin Christian Müller. "Ponatinib Efficacy and Safety in Philadelphia Chromosome-positive Leukemia: Final 5-year Results of the Phase 2 PACE Trial." Blood 132, no. 4 (2018). https://doi.org/10.1182/blood-2016-09-739086.

MLA (9th ed.) Citation

Cortés, Jorge Eduardo, and Martin Christian Müller. "Ponatinib Efficacy and Safety in Philadelphia Chromosome-positive Leukemia: Final 5-year Results of the Phase 2 PACE Trial." Blood, vol. 132, no. 4, 2018, https://doi.org/10.1182/blood-2016-09-739086.